Arteris (NASDAQ:AIP) Major Shareholder Sells $1,310,000.00 in Stock

Key Points

• Bayview Legacy, LLC, a major shareholder of Arteris, Inc. (NASDAQ:AIP), sold 100,000 shares for $1,310,000 on October 6, reducing their stake by 1.02% while retaining about 9.7 million shares worth approximately $127.6 million.
• Arteris stock is currently trading at $13.49, reflecting a 4.2% increase, and has a twelve-month low of $5.46 and high of $14.58.
• Wall Street analysts have mixed ratings on Arteris, with three assigning a "Buy" rating and one a "Sell" rating, and the average target price set at $15.00.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 100,000 shares of the company's stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $13.10, for a total value of $1,310,000.00. Following the sale, the insider owned 9,739,071 shares of the company's stock, valued at approximately $127,581,830.10. This trade represents a 1.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, August 5th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The shares were sold at an average price of $13.12, for a total transaction of $656,000.00.

Arteris Trading Up 4.2%

Arteris stock traded up $0.54 on Wednesday, reaching $13.49. 816,598 shares of the stock were exchanged, compared to its average volume of 570,721. The stock has a market cap of $575.35 million, a PE ratio of -16.45 and a beta of 1.45. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $14.58. The firm has a fifty day moving average price of $9.78 and a two-hundred day moving average price of $8.50.

Arteris (NASDAQ:AIP - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.11). The firm had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. bought a new stake in shares of Arteris during the second quarter worth approximately $32,000. CWM LLC lifted its holdings in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after buying an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. acquired a new position in Arteris in the first quarter valued at approximately $95,000. Savant Capital LLC acquired a new position in Arteris in the second quarter valued at approximately $97,000. Finally, Kapitalo Investimentos Ltda acquired a new position in Arteris in the second quarter valued at approximately $104,000. Institutional investors and hedge funds own 64.36% of the company's stock.

Wall Street Analysts Forecast Growth

AIP has been the subject of a number of analyst reports. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. TD Cowen upped their price objective on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $15.00.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.